Publications by authors named "M Lugtenberg"
Article Synopsis
- This study assessed how well Large Language Models (LLMs) like ChatGPT and Gemini answered melanoma-related patient questions compared to established Dutch patient information resources (PIRs).
- ChatGPT-3.5 had the highest accuracy, while Gemini excelled in completeness, personalization, and readability; however, the best LLMs still lagged behind PIRs in accuracy overall.
- Despite LLMs showing promise for personalized responses, the study highlights the need for improvement in their accuracy and reproducibility before they can fully replace traditional PIRs.
Article Synopsis
- The study focuses on stage I and II melanoma survivors to understand their experiences and survivorship care needs after treatment, highlighting the lack of research in this area despite the rising incidence of localized melanoma.
- The qualitative research involved 18 survivors divided into focus groups, revealing that they experienced significant emotional and physical challenges after treatment, alongside a mix of relief and fear as they navigated life post-diagnosis.
- Survivors emphasized the need for tailored information, accessible resources, and ongoing, patient-centered support to help them adjust and improve their quality of life after melanoma treatment.
From decision to reflection: understanding the experiences and unmet care needs of patients treated with immunotherapy for melanoma in the adjuvant or metastatic setting.
Nadia C W Kamminga Astrid A M van der Veldt Marlies Wakkee Fauve R van den Berge Lianne A A van der Beek Marjolein Lugtenberg
BMC Cancer
May 2024
Article Synopsis
- The study investigates patient experiences and unmet care needs related to immune checkpoint inhibitors (ICIs) in advanced melanoma, focusing on individuals in both adjuvant and metastatic stages.
- Through interviews and focus groups with 35 patients, researchers identified three main themes: decision-making uncertainty, the intense nature of the immunotherapy course, and differing feelings about the treatment experience between adjuvant and metastatic patients.
- Findings highlight the need for tailored guidance and support for patients based on their treatment stage, including options for flexible follow-ups and psychosocial help during the treatment process.